Published Patents

  1. Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereof. Wren, S.P.; Storer, R. et al, WO/2012/11729.

  2. Preparation and analysis of iminosugar acids. Wren, S.P. et al, patent application GB1019461.1

  3. Treatment of C.difficile associated disease, filed 04/08/10 GB1013058.1. Wren, S.P. et al

  4. Treatment of C.difficile associated disease, filed 04/08/10 GB1013060.7. Wren, S.P. et al

  5. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 1009081.9, Wren, S.P. et al

  6. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009085.0, Wren, S.P, et al

  7. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009090.0, Wren, S.P. et al

  8. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009091.8, Wren, S.P. et al

  9. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009094.2, Wren, S.P. et al

  10. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009095.9, Wren, S.P. et al

  11. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009097.5, Wren, S.P. et al

  12. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009104.9, Wren, S.P. et al

  13. Compounds for the treatment of C.difficile associated disease, filed 01/06/10 GB1009108.0 Wren, S.P. et al

  14. Compounds for treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M; Wilson, F.X.; Lecci, C., WO/2010/112091.

  15. Compounds for treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M; Wilson, F.X., WO/2010/112092.

  16. Benzoxazoles for the treatment of Duchenne Muscular Dystrophy. Wren, S.P.; Wynne, G.M; Wilson, F.X.; Poignant, S., WO/2010/112093.

  17. Treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M; Lecci, C.; Wilson, F.X., WO/2010/086040.

  18. Treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M; Lecci, C.; Wilson, F.X.; Price, P.D.; Middleton, P., WO/2010/069684.

  19. Compounds for treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M.; Lecci, C.; Wilson, F.X.; Davis, P.J., WO/2010/057833.

  20. Compounds for treatment of Duchenne muscular dystrophy. Wren, S.P.; Wynne, G.M.; Van Well, R.M.; Schroër, F.; Lecci, C.; Poignant, S.; Ma, S.; Wilson, F., WO/2010/020432.

  21. Compounds for the treatment of flaviral infections.  Wilson, F.X.; Nash, R.J.; Horne, G.; Storer, R.; Tinsley, J.M.; Roach, A.G.; De Moor, O.; Middleton, P.J.; Schroër, F.; Wren, S.P.; Passos Eleuterio, M.I.; Van Well, R.; Dorgan, C.R.; Wynne, G.M., Kawamura, A., WO/2010/015815.

  22. Treatment of lysosomal storage disorders and other proteostatic diseases. Wilson, F.X.; Nash, R.J.; Horne, G.; Storer, R.; Tinsley, J.M.; Roach, A.G.; De Moor, O.; Middleton, P.J.; Schroër, F.; Wren, S.P.; Passos Eleuterio, M.I.; Van Well, R.; Dorgan, C.R.; Wynne, G.M., Kawamura, A., WO/2010/015816.

  23. Compounds for treating muscular dystrophy. Wren, S.P.; Wynne, G.M.; Van Well, R.M.; Chancellor, D.R., Schroër, F., WO/2009/121623.

  24. Treatment of Duchenne muscular dystrophy. Wynne, G.M.; De Moor, O.; Wren, S.P.; Lecci, C.; Van Well, R.; Johnson, P.D.; Storer, R.; Poignant, S., WO/2009/021750.

  25. Treatment of Duchenne muscular dystrophy. Wynne, G.M.; Weymouth-Wilson, A.C.; Clarkson, R.; Van Well, R.; Wren, S.P.; De Moor, O., WO/2009/021749.

  26. Treatment of Duchenne muscular dystrophy. Wynne, G.M.; De Moor, O.; Wren, S.P.; Lecci, C.; Van Well, R.; Johnson, P.D.; Storer, R.; Poignant, S., WO/2009/021747.

  27. Drug combinations for the treatment of Duchenne muscular dystrophy. Wynne, G.M.; Wren, S.P.; Johnson, P.D.; Price, P.D.; De Moor, O.; Nugent, G.; Storer, R.; Pye, R.J.; Dorgan, C.R., WO/2009/019505.

  28. Drug combinations for the treatment of Duchenne muscular dystrophy. Wynne, G.M.; Wren, S.P.; Johnson, P.D.; Price, P.D.; De Moor, O.; Nugent, G.; Storer, R.; Pye, R.J.; Dorgan, C.R., WO/2009/019504.

  29. Compounds for treating Duchenne muscular dystrophy. Wynne, G.M.; Wren, S.P.; Price, P.D., WO 2009013477 A1.

  30. Use of (hetero)aryl compounds for the treatment of Duchenne muscular dystrophy, Becker muscular dystrophy, or cachexia. Wynne, G.M.; Wren, S.P.; Lecci, C., WO 2008029168 A2.

  31. Preparation of imidazopyridines and related compounds for the treatment of Duchenne muscular dystrophy. Wynne, G.M.; Wren, S.P.; Lecci, C., WO 2008029152 A2.

  32. Preparation of benzo[d][1,2,3]triazoles and indazoles for the treatment of muscular dystrophy and cachexia. Wynne, G.M.; Wren, S.P.; Johnson, P.D.; Price, P.D.; De Moor, O.; Nugent, G.; Dorgan, C.R.; Tinsley, J.M.; Storer, R.; Mulvaney, A.; Pye, R.J., WO 2007091107 A1.

  33. Preparation of benzimidazoles, benzoxazoles, benzothiazoles, indoles and their analogs for the treatment of muscular dystrophy and cachexia. Wynne, G.M.; Wren, S.P.; Johnson, P.D.; Price, P.D.; De Moor, O.; Nugent, G.; Tinsley, J.M.; Storer, R.; Mulvaney, A.; Pye, R.J.; Dorgan, C.R., WO 2007091106 A1.

  34. Preparation of fused pyrimidine compounds as histamine H4 modulators.  Harris, N.; Higgs, C.; Wren, S.; Dyke, H.J.; Price, S; Cramp, S., WO 2006050965 A1.

  35. Preparation of phenylindan amino acid derivatives as inhibitors of glycine transport.  Smith, G.P.; Andersen, K.; Wren, S.P.; Harris, N.; Brandt, G., WO 2005087708 A1.

  36. Preparation of quinoline derivatives as MCH-1 receptor modulators.  Dyke, H.J.; Cramp, S.M.; Wren, S.P.; Newton, C.G., WO 2005035521 A1.

  37. Preparation of pyrrolopyrimidine derivatives Useful as modulators of multidrug resistance.  Milton, J.; Wren, S.P.; Wang. S; Folkes, A.; Chuckowree, I.; Hancox, T.; Miller, W.; Sohal, S.; WO 2004065389 A1.

  38. Preparation of aryloxyphenyl and arylsulfanylphenyl derivatives as glycine transport inhibitors.  Smith, G.P.; Mikkelsen, G.; Andersen, K.; Greve, D.; Ruhland, T.; Wren, S.P., WO 2003053942 A1.